Germinal Center–Like Tertiary Lymphoid Structures Mark Immune Responsiveness and Enable Checkpoint Immunotherapy in Bladder Cancer
Oncology Research · 2026 · 34 (7) · 1-10
DOI: 10.32604/or.2026.077808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Zhihao Yin und 15 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Tertiary Lymphoid Structures, Germinal Center, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, China.
- Department of Urology, Harbin Medical University Cancer Hospital, Harbin, China.
- Heilongjiang Provincial Key Laboratory of Basic Medical Sciences in Urology Cancer, Harbin Medical University Cancer Hospital, Harbin, China.
- College of Life Sciences, Northeast Forestry University, Harbin, China.
- Department of Urogenital Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
- Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Zitieren
APA
Yin, Z., Zhen, X., Li, H., Duan, H., Hu, X., Yu, T., Shi, Q., Liu, Z., Li, Y., Zhang, P., Dai, P., Zhao, M., Wang, Z., Li, C., Wang, D., & Tong, Z. (2026). Germinal Center–Like Tertiary Lymphoid Structures Mark Immune Responsiveness and Enable Checkpoint Immunotherapy in Bladder Cancer. Oncology Research, 34(7), 1-10. https://doi.org/10.32604/or.2026.077808
Vancouver
Yin Z, Zhen X, Li H, Duan H, Hu X, Yu T, et al. Germinal Center–Like Tertiary Lymphoid Structures Mark Immune Responsiveness and Enable Checkpoint Immunotherapy in Bladder Cancer. Oncology Research. 2026;34(7):1-10. doi:10.32604/or.2026.077808
BibTeX
@article{Yin2026,
author = {Yin, Zhihao and Zhen, Xi and Li, Haonan and Duan, Haiqiang and Hu, Xiaowei and Yu, Tianxi and Shi, Qing and Liu, Ziyi and Li, Yaowei and Zhang, Peng and Dai, Peng and Zhao, Meihui and Wang, Ziqi and Li, Changfu and Wang, Di and Tong, Zhichao},
title = {Germinal Center–Like Tertiary Lymphoid Structures Mark Immune Responsiveness and Enable Checkpoint Immunotherapy in Bladder Cancer},
journal = {Oncology Research},
year = {2026},
volume = {34},
number = {7},
pages = {1--10},
doi = {10.32604/or.2026.077808}
}
EUVIMED